Human peripheral blood polymorphonuclear leukocytes at the ovulatory period are in an activated state

Molecular and Cellular Endocrinology

Volumn 196, Issue 1-2, 2002, Pages 21-28

  Shirai, F ^a   Kawaguchi, M ^a   Yutsudo, M ^b   Dohi, Y ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Luteinizing hormone receptor; Neutrophil; Nitric oxide; Ovulation; Superoxide

Indexed keywords

HYDROGEN PEROXIDE; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR; MESSENGER RNA; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HORMONAL REGULATION; HUMAN; LEUKOCYTE ACTIVATION; MENSTRUAL CYCLE; NEUTROPHIL; OVULATION; PRIORITY JOURNAL; BLOOD; BLOOD CELL; DOSE RESPONSE; DRUG EFFECT; METABOLISM; PHYSIOLOGY;

ADULT; BLOOD CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYDROGEN PEROXIDE; LUTEINIZING HORMONE; MENSTRUAL CYCLE; NEUTROPHIL ACTIVATION; NEUTROPHILS; NITRIC OXIDE; OVULATION; SUPEROXIDES;

EID: 0037206421     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(02)00228-9     Document Type: Article

References (44)

1. Andersen A.G., Als-Nielsen B., Hornnes P.J., Franch Andersen L. Time interval from human chorionic gonadotrophin (HCG) injection to follicular rupture. Hum. Reprod. 10:1995;3202-3205.
2. Andreae W.A. A sensitive method for the estimation of hydrogen peroxide in biological materials. Nature. 175:1995;859-860.
3. Bonello N., McKie K., Jasper M., Andrew L., Ross N., Braybon E., Brannstrom M., Norman R.J. Inhibition of nitric oxide: effects of on interleukin-1β-enhanced ovulation rate, steroid hormones, and ovarian leukocyte distribution at ovulation in the rat. Biol. Reprod. 54:1996;436-445.
4. Brannstrom M., Janson P.O. Biochemistry of ovulation. Hillier S., Ovarian Endocrinology. 1991;132-166 Blackwell, Oxford.
5. Brannstrom M., Mayrhofer G., Robertson S.A. Localization of leukocyte subsets in the rat ovary during the periovulatory period. Biol. Reprod. 48:1993;277-286.
6. Brannstrom M., Wang L., Norman R.J. Ovulatory effect of interleukin-1β on the perfused rat ovary. Endocrinology. 132:1993;399-404.
7. Brannstrom M., Bonello N., Norman R.J., Robertson S.A. Reduction of ovulation rate in the rat by administration of a neutrophil-depleting monoclonal antibody. J. Reprod. Immunol. 29:1995;265-270.
8. Catz S.D., Carreras M.C., Poderoso J.J. Nitric oxide synthase inhibitors decrease human polymorphonuclear leukocyte luminol-dependent chemiluminescence. Free Radic. Biol. Med. 19:1995;741-748.
9. Chanock S.J., Benna J.E.I., Smith R.M., Babior B.M. The respiratory burst oxidase. J. Biol. Chem. 269:1994;24519-24522.
10. Cunnigham F.G., MacDonald P.C., Gant N.F., Leveno K.J., Gilstrap I.I.I.L.C., Hankins G.D.V., Clark S.L. Physiology of pregnancy. Licht J., Williams Obstetrics. 20th ed. 1997;69-93 Appleton & Lange, Connecticut.
11. DeLeo F.R., Allen L.A.H., Apicella M., Nauseef W.M. NADPH oxidase activation and assembly during phagocytosis. J. Immunol. 163:1999;6732-6740.
12. Dohi Y., Nisonoff A. Suppression of idiotype and generation of suppressor T cells with idiotype-conjugated themocytes. J. Exp. Med. 150:1979;909-918.
13. Dufau M.L. The luteinizing hormone receptor. Annu. Rev. Physiol. 60:1998;461-496.
14. Dufau M.L., Catt K.J. Gonadotropin receptors and regulation of steroidogenesis in testis and ovary. Vitam. Horm. 36:1978;461-592.
15. Espey L.L. Ovulation as an inflammatory reaction - a hypothesis. Biol. Reprod. 22:1980;73-106.
16. Faletti A., Perez M.S., Perotti C., de-Gimeno M.A. Activity of ovarian nitric oxide synthase (NOs) during ovulatory process in the rat: relationship with prostagrandins (PGs) production. Nitric Oxide. 3:1999;340-347.
17. Forstermann U., Boissel J.P., Kleinert H. Expressional control of the constitutive isoforms of nitric oxide synthase (NOSI and NOSIII). FASEB J. 12:1998;773-790.
18. Hellberg P., Thomsen P., Janson P.O., Brannstrom M. Leukocyte supplementation increases the luteinizing hormone-induced ovulation rate in the in vitro-perfused rat ovary. Biol. Reprod. 44:1991;791-797.
19. Hurwitz A., Ricciarelli E., Botero L., Rohan R.M., Hernandez E.R., Adashi E.Y. Endocrine-and autocrine-mediated regulation of rat ovarian (theca-interstitial) interleukin-1β gene expression: gonadotropin-dependent preovulatory acquisition. Endocrinology. 129:1991;3427-3429.
20. Lapthorn A.J., Harris D.C., Littlejohn A., Lustbader J.W., Canfield R.E., Machin K.J., Morgan F.J., Isaacs N.W. Crystal structure of human chorionic gonadotropin. Nature. 369:1994;455-461.
21. Li Q., Qi B., Oka K., Shimakage M., Yoshika N., Inoue H., Hakura A., Kodama K., Stanbridge E.J., Yutsudo M. Link of a new type apoptosis-inducing gene ASY/Nogo-B to human cancer. Oncogene. 20:2001;3929-3936.
22. Lin J., Lojun S., Lei Z.M., Wu W.X., Peiner S.C., Rao C.V. Lymphocytes from pregnant women express human chorionic gonadotropin/luteinizing hormone receptor gene. Mol. Cell. Endocrinol. 111:1995;R13-R17.
23. Loy R.A., Loukides J.A., Polan M.L. Ovarian steroids modulate human monocyte tumor necrosis factor alpha messenger ribonucleic acid levels in cultured human peripheral monocytes. Fertil. Steril. 58:1992;733-739.
24. Miller R.A., Britigan B.E. Role of oxidants in microbial pathophysiology. Clin. Microbiol. Rev. 10:1997;1-18.
25. Minegishi T., Nakamura K., Takakura Y., Miyamoto K., Hasegawa Y., Ibuki Y., Igarashi M. Cloning and sequencing of human LH/hCG receptor cDNA. Biochem. Biophys. Res. Commun. 172:1990;1049-1054.
26. Mitsube K., Mikuni M., Matousek M., Brannstrom M. Effects of a nitric oxide donor and nitric oxide synthase inhibitors on luteinizing hormone-induced ovulation in the ex-vivo perfused rat ovary. Hum. Reprod. 14:1999;2537-2543.
27. Nauseef W.M., Metcalf J.A., Root R.K. Role of myeloperoxidase in the respiratory burst of human neutrophils. Blood. 61:1983;483-492.
28. Polan M.L., Loukides J., Nelson P., Carding S., Diamond M., Walsh A., Bottomly K. Progesterone and estradiol modulate interleukin-1β messenger ribonucleic acid levels in cultured human peripheral monocytes. J. Clin. Endocrinol. Metab. 69:1989;1200-1206.
29. Polan M.L., Kuo A., Loukides J., Bottomly K. Cultured human luteal peripheral monocytes secrete increased levels of interleukin-1. J. Clin. Endocrionol. Metab. 70:1990;480-484.
30. Pryor W.A., Squadrito G.L. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am. J. Physiol. 268:1995;L699-L722.
31. Reinholz M.M., Zschunke M.A., Roche P.C. Loss of alternately spliced messenger RNA of the luteinizing hormone receptor and stability of the follicle- stimulating hormone receptor messenger RNA in granulosa cell tumors of the human ovary. Gynecol. Oncol. 79:2000;264-271.
32. Roche P.C., Ryan R.J. Purification, characterization, and amino-terminal sequence of rat ovarian receptor for luteinizing hormone/human choriogonadotropin. J. Biol. Chem. 264:1989;4636-4641.
33. 2: studies with normal and cytochalasin B-treated cells. J. Cin. Invest. 60:1977;1266-1279.
34. 2 release from human granulocytes during phagocytosis. I. Documentation, quantitation, and some regulating factors. J. Clin. Invest. 55:1975;945-955.
35. Sambrook J., Fritsch E.F., Maniatis T. Extraction, purification, and analysis of messenger RNA from eukaryotic cells. Noland C., Molecular Cloning a Laboratory Manual. second ed. 1989;7.1-7.87 Cold Spring Harbor Laboratory, New York.
36. Segal A.W., Jones O.T. The subcellular distribution and some properties of the cytochrome b component of the microbicidal oxidase system of human neutrophils. Biochem. J. 182:1979;181-188.
37. Stuehr D.J., Marletta M.A. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma. J. Immunol. 139:1987;518-525.
38. Takehara Y., Dharmarajan A.M., Kaufman G., Wallach E.E. Effect of interleukin-1β on ovulation in the in vitro perfused rabbit ovary. Endocrinology. 134:1994;1788-1793.
39. Tamate K., Sengoku K., Ishikawa M. The role of superoxide dismutase in the human ovary and fallopian tube. J. Obstet. Gynaecol. 21:1995;401-409.
40. Testart J., Frydman R. Minimum time lapse between luteinizing hormone surge or human chorionic gonadotropin administration and follicular rupture. Fertil. Steril. 37:1982;50-53.
41. Testart J., Frydman R., Feinstein M.C., Thebault A., Roger M., Scholler R. Interpretation of plasma luteinizing hormone assay for the collection of mature oocytes from women: definition of a luteinizing hormone surge-initiating rise. Fertil. Steril. 36:1981;50-54.
42. Wang F., Riley J.C.M., Behrman H.R. Immunosuppressive levels of glucocorticoid block extrauterine luteolysins in the rat. Biol. Reprod. 49:1993;66-73.
43. Wanikiat P., Woodward D.F., Armstrong R.A. Investigation of the role of nitric oxide and cyclic GMP in both the activation and inhibition of human neutrophils. Br. J. Pharmacol. 122:1997;1135-1145.
44. Wu H., Lustbader J.W., Liu Y., Canfield R.E., Hendrickson W.A. Structure of human chorionic gonadotropin at 2.6 Å resolution from MAD analysis of the selenomethionyl protein. Structure. 2:1994;545-558.